|
Stage
|
OS
|
LRRFS
|
DMFS
|
DFS
|
|---|
|
HR (95% CI)
|
P
|
HR (95% CI)
|
P
|
HR (95% CI)
|
P
|
HR (95% CI)
|
P
|
|---|
|
Overall
|
1.14 (0.70–1.87)
|
0.599
|
1.27 (0.62–2.59)
|
0.515
|
1.22 (0.72–2.08)
|
0.456
|
1.16 (0.74–1.81)
|
0.517
|
|
III
|
1.52 (0.68–3.39)
|
0.308
|
2.23 (0.79–6.24)
|
0.119
|
1.62 (0.69–3.80)
|
0.259
|
1.62 (0.83–3.16)
|
0.155
|
|
IV
|
1.04 (0.55–1.96)
|
0.912
|
0.65 (0.21–1.98)
|
0.440
|
1.11 (0.55–2.21)
|
0.777
|
0.92 (0.50–1.70)
|
0.789
|
|
T1–2
|
0.70 (0.14–3.48)
|
0.663
|
50.52 (0–6.22 × 108)
|
0.386
|
0.48 (0.11–2.17)
|
0.332
|
0.65 (0.16–2.60)
|
0.537
|
|
T3–4
|
1.23 (0.73–2.07)
|
0.430
|
1.25 (0.61–2.57)
|
0.548
|
1.41 (0.80–2.49)
|
0.237
|
1.27 (0.79–2.02)
|
0.325
|
|
N0–1
|
1.17 (0.60–2.28)
|
0.638
|
1.38 (0.55–3.47)
|
0.487
|
1.12 (0.54–2.32)
|
0.766
|
1.08 (0.60–1.94)
|
0.797
|
|
N2–3
|
1.11 (0.52–2.37)
|
0.783
|
1.01 (0.31–3.30)
|
0.990
|
1.42 (0.66–3.07)
|
0.370
|
1.27 (0.64–2.52)
|
0.487
|
-
OS overall survival, LRRFS locoregional relapse-free survival, DMFS distant metastasis-free survival, DFS disease-free survival, HR hazard ratio, CI confidence interval. Other abbreviations as in Table 1
